Impax Group PLC
19 December 2007
Impax Group PLC
Employee Incentive Arrangement
19 December 2007
Impax Group plc ('Impax', the 'Group' or the 'Company')
The Company has today issued a circular (the 'Circular') to Shareholders seeking
approval of proposals to extend the operation of the Impax Group Employee
Benefit Trust 2005 ('the EBT'), pursuant to which awards of Ordinary Shares have
been made for the benefit of employees of the Group and their families, in
relation to the three financial years ending 30 September 2010 and the issue of
a maximum of 18,250,000 Ordinary Shares under the EBT.
Copies of the Circular may be obtained from the Company's registered office,
Broughton House, 6-8 Sackville Street, London W1S 3DG or may be downloaded from
the Company's website at www.impax.co.uk.
Background
In January 2005 Shareholders approved the establishment by the Company of the
Impax Group Employee Benefit Trust 2005 ('EBT' or 'Incentive Arrangement') for
the purposes, inter alia, of the grant of awards of Ordinary Shares to employees
of the Group. The purpose of establishing the Incentive Arrangement was to
motivate and incentivise eligible participants to achieve value for
Shareholders. The maximum number of Ordinary Shares that may be issued under
the Incentive Arrangement as approved by Shareholders was limited to 18,250,000
Ordinary Shares.
In January 2007, the remuneration committee proposed that the limit on the
maximum number of Ordinary Shares that may be issued under the Incentive
Arrangement be increased to 24,250,000 Ordinary Shares for the purposes of
making awards under the Incentive Arrangement in respect of the financial year
ended 30 September 2007. However, following discussions with certain
Shareholders, the Board concluded that it should design and put forward new
long-term incentive arrangements rather than seek approval of an increase in the
number of Ordinary Shares in respect of which awards could be made only in
relation to the financial year ending 30 September 2007.
Since February 2007 the remuneration committee has formulated the proposals set
out in the Circular to operate the Incentive Arrangement in relation to the
three financial years of the Company ending 30 September 2008, 2009 and 2010 and
to issue a maximum of 18,250,000 Ordinary Shares under the Incentive Arrangement
in respect of the three financial years ending 30 September 2010.
Further details of the EBT and the proposals are set out in the Circular.
Extraordinary General Meeting
An extraordinary general meeting of the Company will be held on 31 January 2008
for the purpose, inter alia, of considering a resolution to approve the
operation of the EBT in relation to the three financial years ending 30
September 2010 and the increase in the number of Ordinary Shares that may be
issued under the EBT. The resolutions to be proposed at the extraordinary
general meeting are set out in the notice of the meeting which is contained
within the Circular.
For further information please contact
Impax Group plc 020 7434 1122
Ian Simm, Chief Executive
Landsbanki Securities (UK) Limited 020 7426 9000
Mark Dickenson, Managing Director
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.